Inauguration of the new offices at León Technological Parque. Trailblazing and creating memories!

Syva’s administrative services were inaugurated on 22nd November 2019 and its new offices have been inverted. They are now located in the heart of the Technological Park, just opposite the other Syva buildings, aimed for vaccine production and the betalactam antibiotic production unit.

A total of 80 employees share more than 400 square metres distributed over 3 platforms. Designed to boost exchange between the various departments and increase the ease of use, the new group landscape combines sales and marketing, customer services, human resources and IT support. A full platform is also dedicated to laboratories for the development of new animal health medicines and is occupied by the 12 scientific collaborators in charge of research and development at Syva.

You may also be interested in

30 August, 2023

New tool for controlling erysipelas and PPV: Syvac® Ery Parvo

Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.

Read more

19 July, 2023

Interview with Inés Ruedas, winner of the Syva Award 2023 – Tierras Porcino

We could not miss this excellent interview, conducted by Interempresas for Tierras Porcino, which recently interviewed our Syva 2022 award winner, Inés Ruedas Torres, about her thesis and the numerous challenges that the pig sector faces in the fight against PRRSV. In her interview, Inés speaks about the new advances in the fight against this disease, but also about the...

Read more

2 March, 2023

SYVA announces its partnership with the biotech SMIVET for the development of SDA [SDA]

León - Technology Park – Spain, March 2, 2023 - SYVA and SMIVET signed a collaboration agreement that allow both companies to develop therapeutic solutions based on Single Domain Antibodies (SDA). With this agreement, Syva expresses its willingness to invest in new biotechnologies with the objective to continue to grow and improve its attractiveness by researching, developing, and producing...

Read more